PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
5.68%
Some net income increase while RRC is negative at -528.38%. John Neff would see a short-term edge over the struggling competitor.
-15.45%
Both reduce yoy D&A, with RRC at -100.00%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
6.23%
Some yoy growth while RRC is negative at -377.09%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
366.67%
SBC growth well above RRC's 14.71%. Michael Burry would flag major dilution risk vs. competitor’s approach.
1933.33%
Slight usage while RRC is negative at -59.94%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1933.33%
Growth well above RRC's 85.26%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-38.95%
Negative yoy while RRC is 2798.52%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-38.17%
Both yoy CFO lines are negative, with RRC at -24.28%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-0.95%
Negative yoy CapEx while RRC is 13.71%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-83.29%
Negative yoy acquisition while RRC stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-116.44%
Both yoy lines negative, with RRC at -226.61%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
442.34%
1.25-1.5x RRC's 307.76%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
0.99%
We have some outflow growth while RRC is negative at -72.58%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-354.10%
We reduce yoy invests while RRC stands at 13.36%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-1508.54%
Both yoy lines negative, with RRC at -6.88%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-100.00%
Negative yoy issuance while RRC is 179.50%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.